TABLE 2.
The studies on materials reducing inflammation.
| Surface modification | IOL optic materials | Technique | Article |
|---|---|---|---|
| HEP* | PMMA | Larsson et al. (1989) | |
| PMMA, Silicon | Arthur et al. (2001) | ||
| Hydrophobic acrylic | Krall et al. (2014) | ||
| PMMA | Rønbeck and Kugelberg, (2014) | ||
| PEG* | Hydrophobic acrylic | APGD* | Lin et al. (2010) |
| NVP* | Hydrophobic acrylic | Wang et al. (2013) | |
| MPC* | Hydrophobic acrylic | Ultraviolt irradiation | Huang et al. (2017) |
| Silicon | SI-RAFT* | Han et al. (2017) | |
| MPC-MAA* | Hydrophobic acrylic | Plasma | Tan et al. (2017) |
| Recombinant hirudin anticoagulant | Hydrophobic acrylic | Ammonia plasma | Zheng et al. (2016) |
*HEP, heparin; PEG, poly (Ethylene Glycol); NVP, N-vinyl pyrrolidone; MPC, 2-methacryloyloxyethyl phosphorylcholine; MAA, methyl acrylic acid; APGD, atmospheric pressure glow discharge; SI-RAFT, surface-initiated reversible addition-fragmentation chain transfer.